Vineti

company

About

Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.

  • 251 - 500

Details

Last Funding Type
Series C
Last Funding Money Raised
$35M
Industries
Biotechnology,Cloud Computing,Enterprise Software,Software,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
251 - 500
Operating Status
Active

Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.

The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine.

Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$35M
Vineti has raised a total of $35M in funding over 2 rounds. Their latest funding was raised on Feb 5, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 5, 2020 Series C $35M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Vineti is funded by 1 investors. Kite Pharma are the most recent investors.
Investor Name Lead Investor Funding Round
Kite Pharma Series C